Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Drug development in small cell and non-small cell lung cancer

Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies

ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma

Increased risk of breast cancer among young women treated with radiation as a child

First effective treatment for chemotherapy-induced peripheral neuropathy

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies

Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours

Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival

Primary and secondary resistance in colorectal cancer